Elucidating the mechanism of action of domatinostat (4SC-202) in cutaneous T cell lymphoma cells

BACKGROUND: Targeting epigenetic modifiers is effective in cutaneous T cell lymphoma (CTCL). However, there is a need for further improvement of this therapeutic approach. Here, we compared the mode of action of romidepsin (FK228), an established class I histone deacetylase inhibitor, and domatinost...

Descripción completa

Detalles Bibliográficos
Autores principales: Wobser, Marion, Weber, Alexandra, Glunz, Amelie, Tauch, Saskia, Seitz, Kristina, Butelmann, Tobias, Hesbacher, Sonja, Goebeler, Matthias, Bartz, René, Kohlhof, Hella, Schrama, David, Houben, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423872/
https://www.ncbi.nlm.nih.gov/pubmed/30885250
http://dx.doi.org/10.1186/s13045-019-0719-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423872/
https://www.ncbi.nlm.nih.gov/pubmed/30885250
http://dx.doi.org/10.1186/s13045-019-0719-4

Ejemplares similares